226 related articles for article (PubMed ID: 23328810)
1. Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007.
Towner RA; Gillespie DL; Schwager A; Saunders DG; Smith N; Njoku CE; Krysiak RS; Larabee C; Iqbal H; Floyd RA; Bourne DW; Abdullah O; Hsu EW; Jensen RL
Neuro Oncol; 2013 Mar; 15(3):330-40. PubMed ID: 23328810
[TBL] [Abstract][Full Text] [Related]
2. OKN-007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model.
de Souza PC; Balasubramanian K; Njoku C; Smith N; Gillespie DL; Schwager A; Abdullah O; Ritchey JW; Fung KM; Saunders D; Jensen RL; Towner RA
J Magn Reson Imaging; 2015 Dec; 42(6):1582-91. PubMed ID: 25920494
[TBL] [Abstract][Full Text] [Related]
3. OKN-007 decreases free radical levels in a preclinical F98 rat glioma model.
Coutinho de Souza P; Smith N; Atolagbe O; Ziegler J; Njoku C; Lerner M; Ehrenshaft M; Mason RP; Meek B; Plafker SM; Saunders D; Mamedova N; Towner RA
Free Radic Biol Med; 2015 Oct; 87():157-68. PubMed ID: 26119786
[TBL] [Abstract][Full Text] [Related]
4. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
[TBL] [Abstract][Full Text] [Related]
5. Association of decreased levels of lipopolysaccharide-binding protein with OKN-007-induced regression of tumor growth in an F98 rat glioma model.
Smith N; Saunders D; Jensen RL; Towner RA
J Neurosurg; 2019 Oct; 133(6):1695-1703. PubMed ID: 31628293
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas.
Jensen RL; Ragel BT; Whang K; Gillespie D
J Neurooncol; 2006 Jul; 78(3):233-47. PubMed ID: 16612574
[TBL] [Abstract][Full Text] [Related]
7. Metronomic treatment of malignant glioma xenografts with irinotecan (CPT-11) inhibits angiogenesis and tumor growth.
Takano S; Kamiyama H; Mashiko R; Osuka S; Ishikawa E; Matsumura A
J Neurooncol; 2010 Sep; 99(2):177-85. PubMed ID: 20066473
[TBL] [Abstract][Full Text] [Related]
8. ELTD1, a potential new biomarker for gliomas.
Towner RA; Jensen RL; Colman H; Vaillant B; Smith N; Casteel R; Saunders D; Gillespie DL; Silasi-Mansat R; Lupu F; Giles CB; Wren JD
Neurosurgery; 2013 Jan; 72(1):77-90; discussion 91. PubMed ID: 23096411
[TBL] [Abstract][Full Text] [Related]
9. Targeting nitric oxide and NMDA receptor-associated pathways in treatment of high grade glial tumors. Hypotheses for nitro-memantine and nitrones.
Altinoz MA; Elmaci İ
Nitric Oxide; 2018 Sep; 79():68-83. PubMed ID: 29030124
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts.
Coutinho de Souza P; Mallory S; Smith N; Saunders D; Li XN; McNall-Knapp RY; Fung KM; Towner RA
PLoS One; 2015; 10(8):e0134276. PubMed ID: 26248280
[TBL] [Abstract][Full Text] [Related]
11. Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity.
Hsieh CH; Lee CH; Liang JA; Yu CY; Shyu WC
Oncol Rep; 2010 Dec; 24(6):1629-36. PubMed ID: 21042761
[TBL] [Abstract][Full Text] [Related]
12. ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models.
Ziegler J; Pody R; Coutinho de Souza P; Evans B; Saunders D; Smith N; Mallory S; Njoku C; Dong Y; Chen H; Dong J; Lerner M; Mian O; Tummala S; Battiste J; Fung KM; Wren JD; Towner RA
Neuro Oncol; 2017 Feb; 19(2):175-185. PubMed ID: 27416955
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.
Ji X; Wang H; Zhu J; Zhu L; Pan H; Li W; Zhou Y; Cong Z; Yan F; Chen S
Int J Cancer; 2014 Aug; 135(3):574-84. PubMed ID: 24374745
[TBL] [Abstract][Full Text] [Related]
14. Visualization of the protective ability of a free radical trapping compound against rat C6 and F98 gliomas with diffusion tensor fiber tractography.
Asanuma T; Doblas S; Tesiram YA; Saunders D; Cranford R; Yasui H; Inanami O; Smith N; Floyd RA; Kotake Y; Towner RA
J Magn Reson Imaging; 2008 Sep; 28(3):574-87. PubMed ID: 18777527
[TBL] [Abstract][Full Text] [Related]
15. OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma.
Thomas L; Smith N; Saunders D; Zalles M; Gulej R; Lerner M; Fung KM; Carcaboso AM; Towner RA
J Transl Med; 2020 Nov; 18(1):424. PubMed ID: 33168005
[TBL] [Abstract][Full Text] [Related]
16. Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography.
Doblas S; He T; Saunders D; Pearson J; Hoyle J; Smith N; Lerner M; Towner RA
J Magn Reson Imaging; 2010 Aug; 32(2):267-75. PubMed ID: 20677250
[TBL] [Abstract][Full Text] [Related]
17. Role of Protease-Activated Receptor-1 in Glioma Growth.
Xie Q; Bao X; Chen ZH; Xu Y; Keep RF; Muraszko KM; Xi G; Hua Y
Acta Neurochir Suppl; 2016; 121():355-60. PubMed ID: 26463974
[TBL] [Abstract][Full Text] [Related]
18. Effects of the nitric oxide donor JS-K on the blood-tumor barrier and on orthotopic U87 rat gliomas assessed by MRI.
Weidensteiner C; Reichardt W; Shami PJ; Saavedra JE; Keefer LK; Baumer B; Werres A; Jasinski R; Osterberg N; Weyerbrock A
Nitric Oxide; 2013 Apr; 30():17-25. PubMed ID: 23370169
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
[TBL] [Abstract][Full Text] [Related]
20. PTK787/ZK222584, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decreases glioma growth and vascularization.
Goldbrunner RH; Bendszus M; Wood J; Kiderlen M; Sasaki M; Tonn JC
Neurosurgery; 2004 Aug; 55(2):426-32; discussion 432. PubMed ID: 15271251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
